^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    CANCER:

    Esophageal Squamous Cell Carcinoma

    Related cancers:
    1d
    TD-NEOE3V3: Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma (clinicaltrials.gov)
    P3, N=390, Not yet recruiting, Tang-Du Hospital | Initiation date: May 2025 --> Feb 2026
    Trial initiation date
    |
    cisplatin • docetaxel • 5-fluorouracil • Loqtorzi (toripalimab-tpzi) • albumin-bound paclitaxel
    1d
    Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy (clinicaltrials.gov)
    P2, N=73, Not yet recruiting, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
    New P2 trial
    3d
    Analysis of Disease Burden, Treatment Patterns, and Prognostic Differences of Different Subtypes of Early/Late-Onset Esophageal Cancer Based on Multi-Databases from a China-US Comparative Perspective and Construction of Survival Prediction Models (ChiCTR2600117727)
    P=N/A, N=1296, Not yet recruiting, The First Affiliated Hospital of Army Medical University; The First Affiliated Hospital of Army Medical University
    New trial
    3d
    Observation of the Efficacy of Radiofrequency Ablation Therapy in Patients with Barrett's Esophagus: A Prospective Study (ChiCTR2600117715)
    P=N/A, N=72, Not yet recruiting, Qilu Hospital of Shandong University; Qilu Hospital of Shandong University
    New trial
    3d
    Prophylactic Chemoradiotherapy Versus Surveillance After Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma: A Multicenter Randomized Trial (ChiCTR2600117581)
    P=N/A, N=160, Not yet recruiting, Southern Medical University Shenzhen Hospital; Southern Medical University Shenzhen Hospital
    New trial
    3d
    Effectiveness of Platelet-Rich Plasma for the Healing of Ulcers after Esophageal Endoscopic Submucosal Dissection: A Single-Center, Randomized, Controlled Clinical Study (ChiCTR2600116841)
    P=N/A, N=42, Recruiting, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; Department of Gastroenterology and Hepatology, Jinling Hospital, Affiliat
    New trial
    3d
    A Multicenter Retrospective Study Comparing the Efficacy of Neoadjuvant Chemoradiotherapy Combined with Immunotherapy versus Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma (ChiCTR2600116739)
    P=N/A, N=350, Not yet recruiting, Sun Yat-sen University Cancer Center; Sun Yat-sen University Cancer Center
    New trial
    3d
    A Prospective, Single-arm, Exploratory Study of Aipalolitovorilimab Combined with Anlotinib and Low-dose Radiotherapy in the Treatment of Advanced Esophageal Cancer with Prior Immunotherapy Failure. (ChiCTR2600116202)
    P=N/A, N=30, Not yet recruiting, Anhui Provincial Cancer Hospital.; Anhui Provincial Cancer Hospital
    New trial
    |
    Focus V (anlotinib)
    3d
    Indocyanine Green-Guided Omental Shield Anastomosis (ICG-OSA) for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy: A Single-Center, Single-Arm, Open-Label Clinical Study (ChiCTR2600116084)
    P=N/A, N=73, Not yet recruiting, Army Medical Center, Army Medical University; Army Medical Center, Army Medical University
    New trial
    3d
    Mechanism exploration of macrophage polarization-mediated tumor microenvironment remodeling in the prognosis of ESCC via SUMOylation and De-SUMOylation of Piezo1 (ChiCTR2600115954)
    P=N/A, N=100, Not yet recruiting, Ningbo Medical Centre Lihuili Hospital; Ningbo Medical Centre Lihuili Hospital
    New trial
    3d
    A Single-Center, Randomized, Controlled Clinical Study Comparing Inflatable Mediastinoscopy Combined with Laparoscopy versus Thoracolaparoscopy Combined with McKeown Esophagectomy in the Treatment of Esophageal Squamous Cell Carcinoma (ChiCTR2500115732)
    P=N/A, N=90, Not yet recruiting, ‌Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
    New trial
    3d
    A Randomized, Controlled, Multicenter Phase Ⅲ Trial of Sintilimab as Consolidation Therapy in Unresectable ESCC Patients Without Disease Progression After Concurrent Taxane-Based Chemoradiotherapy (ChiCTR2500115299)
    P=N/A, N=258, Completed, Jiangsu Cancer Hospital; Jiangsu Cancer Hospital
    New trial
    |
    Tyvyt (sintilimab)